The noncoding RNA miR-125b has been described to reduce ErbB2 protein expression as well as proliferation and migration of cancer cell lines. As additional target of miR-125b, we identified the c-raf-1 mRNA by sequence analysis. We designed a short hairpin-looped oligodeoxynucleotide (ODN) targeted to the same 3′ untranslated region of c-raf-1 mRNA as miR-125b. The fully complementary ODN antisense strand is linked to a second strand constituting a partially double-stranded structure of the ODN. Transfection of the c-raf-1-specific ODN (ODN-Raf) in a breast cancer cell line reduced the protein levels of C-Raf, ErbB2, and their downstream effector cyclin D1 similar to miR-125b. MiR-125b as well as ODN-Raf showed no effect on the c-raf-1 mRNA level in contrast to small interfering RNA. Unlike miR-125b, ODN-Raf induced a cytopathic effect. This may be explained by the structural properties of ODN-Raf, which can form G-tetrads. Thus, the short hairpin-looped ODN-Raf, targeting the same region of c-raf-1 as miR-125b, is a multifunctional molecule reducing the expression of oncoproteins and stimulating cell death. Both features may be useful to interfere with tumor growth. (Mol Cancer Res 2009;7(10):1635-44) 
Introduction
MicroRNAs (miR) are a class of endogenous noncoding single-stranded RNAs ∼22 nucleotides (nt) in length, which are incorporated in the RNA-inducing silencing complex (1) . RNA-inducing silencing complex and miRs regulate the amount of protein expressed from coding RNAs by translational repression or by cleavage of the target mRNA due to base pairing with the 3′ untranslated region (UTR). MiRs have been linked to essential physiologic processes such as regulation of proliferation, differentiation, and apoptosis (1) (2) (3) (4) and to several diseases including cancer (5, 6) .
Silencing of gene expression can be mediated by miRs, single-stranded antisense DNA (asDNA), short hairpin-looped oligodeoxynucleotides (ODN), or small interfering RNAs (siRNA; refs. 7-10). These molecules exert different functions. SiRNA and asDNA primarily lead to reduction of mRNA by cleavage, whereas miRs primarily block translation (11) (12) (13) . Inhibition of translation has also been described for asDNA as secondary effect (14, 15) . ODNs are a special class of short hairpin-looped DNAs that can induce cleavage of viral RNAs via a retroviral or cellular RNase H and therefore are active as antiviral agents (16) (17) (18) (19) (20) .
Only miRs are endogenously expressed and can be deregulated in cancer tissue. Thus, miRs targeted to mRNAs are possible targets for cancer therapy (4, 21, 22) . The mitogen-activated protein kinase pathway, composed of the kinases Raf, mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase, and ERK, controls the proliferation and survival of cells (23) . Deregulation of this pathway is characteristic for many human tumors. Accordingly, activating mutants of Raf proteins and upstream elements such as receptor tyrosine kinases and Ras proteins were identified in these tumors (24) (25) (26) (27) (28) .
Small inhibitory molecules such as asDNA, siRNA, and antibodies have been developed to target the mitogen-activated protein kinase pathway (29) . Recently, it has been described that miR-125b, which is downregulated in breast cancer cells, targets the mRNA of erbB2 (3) . Overexpression of miR-125b inhibited the proliferation and migration of breast cancer cells (30) .
We asked whether Raf proteins might be targets of miRs. We identified by database analysis the 3′UTR of c-raf-1 as a putative target of miR-125b and show here miR-125b-dependent inhibition of C-Raf protein expression. Based on this information, we designed a Raf-specific hairpin-loop-structured ODN (ODN-Raf), one arm of which was fully complementary to c-raf mRNA. Here we show that ODN-Raf can reduce the expression of C-Raf and ErbB2. In addition, ODN-Raf was able to induce cell death, which we did not observe with miR-125b or siRNA-Raf. We speculate that structural properties of the ODN-Raf contribute to this effect, for example, the ability to form G-tetrads. Thus, ODNRaf is a multifunctional molecule that reduces proliferation by inhibition of oncogene expression and induces cell death. (1, 8, 17, 19, 20, 31, 32) . The 3′UTRs of mRNAs are preferred target sites for miRs and play an essential role in translational control and in the stability of transcripts (13, 33) . MiR-125b has been recently described to target erbB2 mRNA (30) . Using the miRBase sequence database from Sanger (version 4), we identified an additional putative cancer relevant target site for miR-125b in the 3′UTR of c-raf-1 with a score of 15.65 and energy of −21.45 (Fig. 1A) .
We asked whether an ODN targeting c-raf-1 mRNA at the same site as miR-125b could mimic such effects. We designed a hairpin-looped ODN of 54 nt containing a fully complementary antisense strand of 25 nt targeting the same site on the 3′ UTR of c-raf-1 as miR-125b ( Fig. 1A and B) . The antisense strand is linked by four thymidines to a second strand of 25 nt, which itself is partially complementary to the antisense strand. The ODN-Raf antisense strand is also partially complementary to the target site of miR-125b in the 3′UTR of erbB2 mRNA (11 of 26 nt are complementary; Fig. 1A ). Both the antisense and the second strand are G-rich. Three nucleotides at both ends and the linker contain phosphorothioate-modified nucleotides to protect against nucleases. Control ODNs used in this study carry an antisense and a second strand noncomplementary to c-raf-1 or erbB2 mRNA. The ODN designated as ODN-G-rich is not complementary to c-raf-1 or erbB2 mRNA but carries five G-tracts and was designed to investigate the potential influence of G-tracts. Various controls were used to show specificity (Fig. 1B) .
Effect of miR-125b on C-Raf Protein Expression
We used two human breast cancer cell lines, a noninvasive cell line, MDA-MB-453, and a highly invasive cell line, MDA-MB-231, which have been analyzed in previous studies with miRs (3, 34) . MiR-125b expression level in MDA-MB-453 cells is reduced compared with MDA-MB-231 cells ( Fig. 2A) . C-Raf and ErbB2 are differentially expressed in both cell lines, whereby their higher expression in MDA-MB-453 cells correlated with the reduced miR-125b level ( Fig. 2B and C) . Transfection of MDA-MB-453 cells with miR-125b led to a 400-fold increase of miR-125b compared with mock-transfected cells (Fig. 2D ). As expected, the increase of miR-125b reduced ErbB2 protein levels by 70% compared with mocktransfected cells (Fig. 2B and C) . In addition, transfection of miR-125b reduced the levels of C-Raf protein by 50% ( Fig. 2E and F) . This indicates that miR-125b can target the 3′UTR region of c-raf-1 mRNA as predicted from our in silico analysis.
Effect of ODN-Raf and miR-125b on the Expression of C-Raf and Cyclin D1 Proteins MiRs, asDNA, as well as siRNA can reduce the protein levels expressed from a target gene. The cellular effects of short hairpin-looped ODNs are less well characterized but can affect viral mRNA levels, especially in the presence of a viral RNase H (18) (19) (20) . We asked what effect on protein expression could be observed after transfection of ODN-Raf. A single transfection of 25 or 50 nmol/L ODN-Raf in MDA-MB-453 cells reduced the levels of C-Raf after 24 hours by 35% and 65%, respectively, compared with mock transfection (Fig. 3A) . A similar reduction was also observed for asDNARaf and siRNA-Raf (Fig. 3B) . The siRNA-Raf was a commercially available validated siRNA (35) against a different target site on c-raf-1 mRNA (Fig. 1A) . The quantification of five independent experiments revealed that these reductions were statistically significant (Fig. 3C ). Higher concentrations of oligonucleotides up to 500 nmol/L or longer incubation up to 72 hours did not improve the effect further (data not shown). Also, ErbB2 levels were reduced by ODN-Raf ( Fig. 3A and B) similarly as by miR-125b (Fig. 2F) . AsDNARaf decreased ErbB2 but to a lower extent. The reduction of ErbB2 can be explained by the fact that both ODNs are complementary to a stretch of 11 nt in the erbB2 mRNA (Fig. 1A) . SiRNA-Raf did not significantly alter ErbB2 expression but was specific for c-raf-1 (Fig. 3B) .
The cell cycle regulator cyclin D1 is regulated by both Raf and ErbB2 via the ERK pathway (36, 37) . Consistently, ODNRaf strongly decreased cyclin D1 levels in MDA-MB-453 cells ( Fig. 3A and B) . Thus, ODN-Raf resulted in a transient reduction of C-Raf, ErbB2, and their downstream effector cyclin D1. Also, in the highly invasive breast cancer cell line MDA-MB-231, transfection of ODN-Raf reduced C-Raf protein expression up to 80% compared with untreated cells, 24 hours after transfection (Fig. 3D) . Thus, in two breast cancer cell lines, ODN-Raf inhibited C-Raf expression.
Cholesterol Conjugation of ODNs Can Replace Transfection Reagents
3′-Cholesterol modifications of miRs can lead to enhanced transfection efficiencies and even allow in vivo transfections (38, 39) . Therefore, we analyzed cholesterol-modified ODNRaf for an effect on C-Raf levels. Transfection of MDA-MB-453 cells with 50 nmol/L 5′-cholesterol-modified ODN-Raf without transfection reagent did not affect C-Raf level, whereas 500 nmol/L decreased C-Raf level by 65%, similar to 50 nmol/L nonmodified ODN-Raf transfected with Lipofectamine 2000 (Fig. 4) . Accordingly, cyclin D1 was similarly reduced under these conditions. This result indicates that 5′-cholesterolmodified ODNs require a 10 times higher concentration of ODN in the absence of a transfection reagent.
Influence of ODN-Raf and miR-125b on C-Raf-1 mRNA Levels
Initially, miRs were thought to negatively regulate protein expression solely by inhibiting mRNA translation (13, 40, 41) . However, in recent studies, it has been shown that some miRs could also induce rapid decay of mRNA transcripts (13) . Thus far, we have shown that miR-125b and ODN-Raf reduced the level of C-Raf. To test whether transfection of ODN-Raf and miR-125b also affected the mRNA level, we used a commercially available highly sensitive quantitative real-time reverse transcription-PCR (RT-PCR) TaqMan assay for c-raf-1 mRNA. We transfected MDA-MB-453 cells with 50 nmol/L ODN-Raf or miR-125b. Twenty-four hours after transfection, cells were lysed and c-raf-1 mRNA was isolated and analyzed by quantitative real-time RT-PCR and standardized by β-actin mRNA. No significant reduction of c-raf-1 mRNA was observed after transfection of ODN-Raf or miR125b compared with nontransfected cells (Fig. 5A ). As a positive control, we tested siRNA, which is known to act on the transcriptional level. As expected, siRNA-Raf reduced the level of c-raf-1 mRNA transcripts by 66% compared with the untreated cells. AsDNA-Raf reduced the mRNA level of c-raf-1 by 25% compared with untransfected cells. Moreover, ODNRaf did not lead to a significantly increased reduction of c-raf-1 mRNA at different time points between 3 and 48 hours when compared with control 186 or untreated cells (Fig. 5B ). In conclusion, ODN-Raf and miR-125b do not act by degradation of the c-raf-1 mRNA.
ODN-Raf Can Adopt Higher-Ordered Structures
On transfection with ODN-Raf, MDA-MB-453 cells exhibited a strong cytopathic effect, which was not observed for miR125b, miR-125b-DNA, siRNA-Raf, and various control ODNs and only weakly for asDNA-Raf (see below). Because ODNRaf contains four G-tracts ( Fig. 1) , we tested whether it can form higher-ordered structures. ODN-Raf as well as a control ODN-G-rich, which contains five G-tracts, showed in addition to their major bands (∼50 bp), representing the monomer, a second slower-migrating band (Fig. 6A) , which was not detectable with the controls 186 and 187. To determine whether these minor bands correspond to G-tetrads, we analyzed their stability in the presence of monovalent cations because G-tetrads are stabilized by Na + or K + , but not by Li + (42) . Heat denaturation in the presence of Na + -and K + -containing buffer maintained the slower-migrating band, which diminished in the presence of Li + , suggesting a contribution of G-tetrads (Fig. 6B ). Even though they are not abundant, they may play a role. 
Effect of ODN-Raf on Survival
C-Raf is a survival factor, and downregulation of C-Raf or knockout of c-raf-1 can induce cell death (43) . We investigated the effect of ODN-Raf on cell survival by performing an MTS assay. ODN-Raf reduced cell viability by 70% compared with negative controls (Fig. 7A) . We then analyzed the induction of cleavage of poly-(ADP-ribose)-polymerase 1 (PARP-1) as a marker of cell death (44, 45) . Cells transfected with 25 or 50 nmol/L ODN-Raf exhibited a 5-or 7-fold increased amount of cleaved PARP compared with cells transfected with the negative control 373 (Fig. 7B and C) . Similarly effective were the positive control ODN-G-rich as well as 2nd-ODN-Raf. AsDNA-Raf induced PARP cleavage but to a weaker extent. SiRNA-Raf, miR-125b, miR-125b-DNA, and negative controls had no significant effect. Thus, PARP-cleavage on treatment with ODN-Raf may be attributed to its second strand, which might be partially explained by G-tetrad formation.
Discussion
In this study, we characterized the function of a short hairpin-looped ODN, which was targeted to c-raf-1 mRNA, and compared it with miR, asDNA, and siRNA. We have previously described such ODNs as activators of retroviral and cellular RNases H, leading to down-regulation of target RNAs in the presence of a viral RNase H, especially in the case of HIV in cell culture (18) and in patient-derived plasma (46), a model retrovirus in mice (19) , and a lentivirus in the mouse vagina (47) . We could also show that influenza virus production in lung cells and in the lungs of mice can be reduced by treatment with an ODN against influenza polymerase gene (48) possibly involving cellular RNases H. Also, growth of herpes simplex virus-1 could be inhibited by ODNs targeting essential herpes simplex virus-1 genes in vitro (49) . We now asked whether short hairpin-looped ODNs can also target endogenous cellular mRNAs using the example of the proto-oncogene c-raf-1. The target site was selected based on the sequence of the previously described endogenous miR125b targeting ErbB2, which we identified as a miR that potentially also regulates C-Raf. Overexpression of miR-125b in MDA-MB-453 cells clearly reduced Raf and ErbB2 levels ( Fig. 2D-F) . The reduction of C-Raf by miR-125b is in agreement with the observed growth inhibitory response to miR-125b in MCF10A breast epithelial cells independent of their ErbB2 status (30) . MDA-MB-453 cells expressed less miR-125b than did MDA-MB-231 cells, and this correlated with a higher expression of ErbB2 and C-Raf ( Fig. 2A-C) . The increase in protein levels was much more pronounced for ErbB2 than for C-Raf. Given a comparable complementarity of miR-125b to both target sites on erbB2 and c-raf-1 mRNA (Fig. 1A) and a comparable accessibility of these target sites, we speculate that other cell typespecific mechanisms contribute to the strong overexpression of ErbB2 in MDA-MB-453 cells. Although gene amplification does not account for overexpression of ErbB2 in MDA-MB-453 cells (50) , several other mechanisms (51) besides miR-125b are possible.
The reduction of C-Raf by miR-125b suggested that the target site of miR-125b on c-raf-1 is accessible for interfering oligonucleotides. We therefore designed ODN-Raf to target this site. The antisense strand of ODN-Raf was fully complementary to the 3′UTR region of c-raf-1 mRNA and 42% complementary to the 3′UTR region of erbB2 mRNA. The second strand was designed based on an HIV ODN (20) whereby the second strand was partially complementary to the antisense strand. This structure was superior to single-stranded asDNA, which may have been due to improved stability and possibly to secondary structures, which contributed to the antiviral effect (18, 20) . 3 Most asDNAs and ODNs activate RNases H, which cleave and degrade the RNA of DNA-RNA hybrids (15, 20, 52, 53) . AsDNA can also block translation by steric hindrance of the ribosomes (14, 54, 55) , and miRs primarily inhibit translation of proteins (13, 56) . ODN-Raf as well as miR-125b did not lead to a reduction of c-raf-1 mRNA but reduced C-Raf protein levels by 50% (Figs. 3C and 5A ). SiRNA-Raf resulted in a reduction of both c-raf-1 transcripts and C-Raf protein levels by ∼70% (Figs. 3C and 5A ). AsDNA-Raf reduced the protein level by 60% and the mRNA level by 25%. This suggests that ODN-Raf does not allow cleavage of c-raf-1 mRNA by recruitment of cellular RNases H but may interfere with translation, although we cannot exclude a contribution of a posttranslational mechanism. In addition, we observed that ODN-Raf reduced the expression of ErbB2 protein by ∼50% to 60%. This can be explained by a stretch of 11 of 26 nt of ODN-Raf, which is complementary to the erbB2 mRNA.
Both ErbB2 and C-Raf can regulate the expression of cyclin D1, a key regulator of the G 1 checkpoint in the cell cycle (25, 57) . Consistently, ODN-Raf diminished cyclin D1 level. SiRNA-Raf functioned more specifically than did ODN-Raf and reduced C-Raf but not ErbB2. SiRNA did not significantly decrease cyclin D1, indicating that Raf depletion is not sufficient for cyclin D1 reduction under these conditions. Additional downregulation of ErbB2 seems to be responsible for cyclin D1 decrease.
C-Raf is a survival factor that inhibits in a kinase-independent manner the proapoptotic kinases ASK1 (58) and MST2 (59) . Knockout of C-Raf in mice or in C-Raf-deficient cells can cause Fas-induced apoptosis (43, 60) . We observed that transfection of ODN-Raf led to a significant detachment of transfected cells and loss of viability as determined by an MTS assay. Cell death was confirmed by detection of cleaved PARP. Also in this case, siRNA-Raf was not sufficient, indicating that at least in MDA-MB-453 breast cancer cells, an additional function of ODN-Raf was essential to exert its effect. In agreement with this, antisense reagents against mRNAs of c-raf-1 or erbB2 have been described to inhibit proliferation, whereas for apoptosis, coadministration with mitotic inhibitors or DNA alkylating agents is required [Khazak et al. (29) ; Yang et al., 2003]. The additional property in the case of ODN-Raf may depend on structural features. The antisense and the second strand of ODN-Raf consist of two GG and two GGG clusters in a motif, which would allow G-tetrad formation. Consistently, we detected higher-ordered structures of ODN-Raf, which are maintained following heat denaturation in the presence of Na + and K + ions but are lost in the presence of Li + , suggesting that this band may represent G-tetrads (Fig. 6) . Transfection with ODN-Raf and ODN-G-rich, which exhibit putative Gtetrads, induced cleavage of PARP and cell death. Also, 2nd-ODN-Raf and, more weakly, asDNA-Raf induced PARP-cleavage and cell death. Both single-stranded ODNs contain a GGG string and a GG string and might be able to form intermolecular G-tetrads. However, other mechanisms cannot be excluded thus far. One might speculate that reduced C-Raf expression and inhibition of the ERK pathway further enhance this effect.
To enhance the transfection efficiency and to replace transfection reagents in vivo, 3′-cholesterol-modified oligonucleotides have been used (39, 61) . In the present study, we showed that a 5′-cholesterol modification allowed uptake without a transfection reagent but required a 10-fold higher concentration to achieve similar effects (Fig. 4) . Despite this reduced efficiency, the cholesterol modification might be advantageous to overcome toxicity of transfection reagents. Furthermore, other modifications may be useful to further improve ODN-Raf.
In conclusion, our data show that a short hairpin-looped ODN-Raf molecule, which has a fully complementary antisense strand to the potential target site of miR-125b in the 3′UTR of c-raf-1, reduces the endogenous C-Raf protein level and, indirectly, cyclin D1 protein expression. Because ODNRaf also affects ErbB2 due to a partially complementary sequence, this may also influence the expression of cyclin D1 through the ERK pathway. These negative regulatory effects of ODN-Raf are comparable to those of miR-125b. However, ODN-Raf also induces cell death, which might be attributed to both a reduction of Raf levels and the structural properties of ODN-Raf, such as the possibility to form G-tetrads. Thus, the described short-hairpin looped ODN-Raf is a multifunctional molecule that decreases the levels of oncogene proteins and stimulates cell death. Both effects are favorable to interfere with tumor growth. ODNs could be used as an alternative approach in further investigations to reduce oncogenic signaling in tumor cells.
Materials and Methods

Oligonucleotides
Hsa-miR-125b, which yields miR-125b on processing in the cell, was purchased from Dharmacon; all ODNs and asDNAs were from Metabion; and 5′-cholesterol-modified ODNs was from IBA. The two validated siRNAs (Hs_Raf1_6 and Hs_Raf1_5; Qiagen) used in this study target a region different than the 3′UTR of c-raf-1. All sequences are shown in Fig. 1B .
Cell Culture and Transfection
MDA-MB-453 and MDA-MB-231 breast cancer cell lines were obtained from the American Type Culture Collection and were cultivated in DMEM supplemented with 10% FCS.
Two hours before transfection, cells were seeded into six-well plates (4 × 10 5 per well with 2 mL of DMEM containing 10% FCS). Lipofectamine 2000 (Invitrogen Corp.) was used to transfect ODNs, asDNAs, or siRNAs. The transfection mixture was set up in a final volume of 160 μL and included 4 μL of Lipofectamine 2000, OptiMEM (Invitrogen), and the respective oligonucleotide for a final concentration of 50 or 500 nmol/L in the well. HighPerfect (Qiagen) was used to transfect miR-125b. The transfection mix was set up in a final volume of 100 μL and included 12 μL of HighPerfect, OptiMEM, and the respective oligonucleotide for a final concentration of 50 nmol/L in the well. 5′-Cholesterol-modified ODNs were transfected without using a transfection reagent. The prediluted mixture of 80 μL was incubated at room temperature for 15 min and added to the cells. Four hours after transfection, the medium was changed to fresh growth medium.
Preparation of RNA and miRs
Cells were washed twice with ice-cold PBS (137 mmol/L NaCl, 10 mmol/L phosphate, 2.7 mmol/L KCl, pH 7.4) and harvested in 250 μL of RLT lysis buffer (Qiagen) for total RNA extraction. For RNA preparation, the RLT cell suspension was loaded onto shredder columns (Qiagen) and RNA was prepared using the RNeasy Mini Kit (Qiagen) according to the supplier's instructions. Each sample was reverse transcribed using 250 ng of RNA, random hexamers, and the TaqMan High Capacity cDNA Kit (Applied Biosystems). Reverse transcription was carried out at 25°C for 10 min, 37°C for 2 h, and 70°C for 10 min.
MiR was extracted from cells using the miRVana miRNA Isolation Kit (Ambion) according to the supplier's instruction. Extracted miRs were measured with the Nanodrop 1000 Spectrophotometer (NanoDrop Technologies) and adjusted to 20 ng/μL. For miR-125b and small nuclear RNA (snRNA) U6B, reverse transcription was done in a total volume of 10 μL using 20 ng of miRs, the miRVana qRT-PCR Detection Kit (Applied Biosystems), and specific qRT-PCR primers (Applied Biosystems) for either miR-125b or snRNA U6B (NR_002752) according to the supplier's instructions. Reactions were incubated at 37°C for 30 min and 95°C for 10 min. 
Quantitative Real-time RT-PCR
Relative mRNA expression levels were quantified using the transcribed cDNA and a commercially available quantitative real-time RT-PCR TaqMan assay (Applied Biosystems) on an ABI Prism 7500 system (Applied Biosystems). For normalization, a predeveloped β-actin TaqMan assay was used (Applied Biosystems). The amplification was carried out at 50°C for 2 min, 95°C for 10 min, and 50 cycles with 15 s at 95°C and 1 min at 60°C.
The miR expression levels were quantified using the specifically reverse transcribed cDNA, the miRVana qRT-PCR Primer Set for either miR-125 or snRNA U6B (Applied Biosystems), the miRVana qRT-PCR miRNA Detection Kit (Applied Biosystems), and the ABI Prism 7500 system (Applied Biosystems) according to the supplier's instructions. The level of miR-125b was normalized to snRNA U6B (62) . SYBR Green I (Sigma-Aldrich), a nucleic acid stain, was used for real-time monitoring of miR expression. A dilution row of miR-125b (Dharmacon) was used as positive control.
Protein Preparation and Analysis of Protein Expression
Cells were harvested in PBS and centrifuged for 1 min at 13,000 rpm. For Figs. 3 and 7 , adherent and floating cells were harvested. The pellet was resuspended in 75 μL of lysis buffer [50 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 1% NP40 (v/v), 1 mmol/L EDTA (pH 8.0), 2 mmol/L sodium vanadate, 25 mmol/L NaF, complete mini protease inhibitor from Roche] and incubated for 30 min on ice. The lysate was centrifuged for 2 min at 13,000 rpm. The protein amount was determined using the Bradford method (Bio-Rad). For immunoblotting, the following antibodies were used: anti-extracellular signalregulated kinase 2 (anti-ERK2), anti-cyclin D1, anti-Raf-1, anti-α-tubulin (all from SantaCruz Biotechnology, Inc.), anti-PARP, and anti-phospho-stress-activated protein kinase/c-jun NH 2 -terminal kinase (Cell Signalling Technology, Inc.). Bound antibodies were detected by using peroxidase-labeled secondary antibodies (SantaCruz Biotechnology) and immunoblotting and enhanced chemiluminescence detection reagents from Amersham. Scanned immunoblots were analyzed using the image software ImageQuant 5.2 (GE Healthcare).
Analysis of Secondary Structure
To analyze the short hairpin DNAs and potential secondary structures, native 10% polyacrylamide gels were used. Two hundred nanograms of ODN-Raf, control ODNs, and asDNA diluted in 1×PBS were analyzed with a 10% polyacrylamide gel, which was stained with SYBR Green 2 for 10 min and analyzed on a fluorescence imaging system Storm 860 Molecular Imager (GMI, Inc.).
MTS Assay
The effect of ODNs on cell viability was determined by the CellTiter 96 Aqueaous One Solution Cell Proliferation Assay (Promega) using MTS. Cells were seeded in triplicate in a 48-well plate and transfected as described above, and then MTS assay was done according to the manufacturer's instructions 24 h after transfection. The relative viability was calculated by comparison with mock-transfected cells.
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